Pyroptosis-related bioinformatics analysis reveals that IL1A is a prognostic biomarker in oral squamous cell carcinoma

Author:

Chen Gaoxiang1,Shao Tingru1,Lu Xinyan1,Zheng Zenan1,Lv Xiaozhi1

Affiliation:

1. Department of Oral & Maxillofacial Surgery, Zhujiang Hospital, Southern Medical University

Abstract

Abstract Background: Increasing evidence has demonstrated that pyroptosis plays a crucial role in tumor carcinogenesis and progression. However, there is little information concerning pyroptosis-related genes (PRGs) in oral squamous cell carcinoma (OSCC). Purpose of our study was to explore the prognostic value of PRGs in OSCC patients. Materials and methods: RNA-seq and clinical data were downloaded from The Cancer Genome Atlas (TCGA) database and PRGs were extracted from the expression profiles. Then, differentially-expressed analysis and functional enrichment analysis were performed. A prognostic model based on PRGs was constructed in R software. Moreover, comprehensive bioinformatics analyses were used to verify the prognostic model and select pyroptosis-related biomarkers. Results: A total of 35 genes were categorized as differentially-expressed PRGs and Gene Ontology(GO) and Kyoto Encyclopedia of Genes and Genomes(KEGG) analysis showed that these genes were mainly located in inflammasome complex and associated with pyroptosis. CHPM3, GSDMB, IL1A and NLRP1 were used to establish the prognostic model. Risk scores of each patients was calculated by using the risk-score formula and a nomogram was plotted to visually predict the survival of the OSCC patients. Then half-maximal inhibitory concentration (IC50) of 30 common anticancer drugs was analyzed between patients in high-risk and low-risk cohorts. In the end, IL1A was identified as potential pyroptosis-related biomarkers of OSCC. Conclusion: This study established a novel pyroptosis-related prognostic model, provided a novel strategy for predicting the survival of OSCC patients. Moreover, IL1A was identified as an independent pyroptosi-related biomarker and may be a potential target for OSCC.

Publisher

Research Square Platform LLC

Reference54 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries;Sung H;Cancer J Clin,2021

2. Johnson DE, Burtness B, Leemans CR, Lui VWY, Bauman JE, Grandis JR. Head and neck squamous cell carcinoma.NAT REV DIS PRIMERS(2020)6.

3. Autophagy modulators for the treatment of oral and esophageal squamous cell carcinomas;Khan T;MED RES REV,2020

4. Role of SIRT1 in regulation of epithelial-to-mesenchymal transition in oral squamous cell carcinoma metastasis;Chen IC;MOL CANCER,2014

5. Effectors of Pyroptosis;Kovacs SB;TRENDS CELL BIOL,2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3